A total of 16 GO terms were enriched for down-regulated NSDEGs, including cfi (complement factor I) and bcl10 (B-cell CLL/lymphoma 10), and the most significant GO term was “MHC class II protein complex” related to immune response (Supplementary Table S43). This evidence concerns the gene BCL10 and B-cell chronic lymphocytic leukemia.